Compounds
| ID | Spectrum Quality | Annotated Name |
|---|---|---|
| CCMSLIB00000566325 | Bronze | MoNA:688742&Nystatin |
| CCMSLIB00000566338 | Bronze | MoNA:688786&Nystatin |
| CCMSLIB00000566568 | Bronze | MoNA:688757&Nystatin |
| CCMSLIB00000566702 | Bronze | MoNA:692831&Nystatin |
| CCMSLIB00000566825 | Bronze | MoNA:688785&Nystatin |
| CCMSLIB00000566883 | Bronze | MoNA:695535&Nystatin |
| CCMSLIB00000566885 | Bronze | MoNA:693064&Nystatin |
| CCMSLIB00000566923 | Bronze | MoNA:686832&Nystatin |
| CCMSLIB00000566960 | Bronze | MoNA:688753&Nystatin |
| CCMSLIB00000566972 | Bronze | MoNA:693456&Nystatin |
| CCMSLIB00000566991 | Bronze | MoNA:688734&Nystatin |
| CCMSLIB00000569857 | Bronze | MoNA:1049899&(1S,3R,4R,7R,9R,11R,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(3-Amino-3,6-dideoxy-?-D-mannopyranosyl)oxy]-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabic&yclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic&acid |
| CCMSLIB00004689832 | Bronze | NYSTATIN |
| CCMSLIB00004689833 | Bronze | NYSTATIN |
| CCMSLIB00005435898 | Bronze | Nystatin |
| CCMSLIB00005730009 | Gold | 3 |
| CCMSLIB00005732936 | Gold | 3 |
| CCMSLIB00005734651 | Gold | 3 |
| CCMSLIB00005735835 | Gold | 3 |
| CCMSLIB00005731391 | Gold | 3 |
| CCMSLIB00005730138 | Gold | 3 |
| CCMSLIB00005734202 | Gold | 3 |
| CCMSLIB00005735463 | Gold | 3 |
| CCMSLIB00005733254 | Gold | 3 |
| CCMSLIB00005730936 | Gold | 3 |
| CCMSLIB00005736113 | Gold | 3 |
| CCMSLIB00005731771 | Gold | 3 |
| CCMSLIB00006718028 | Gold | 1 |
| CCMSLIB00012114150 | Gold | 4 |
| CCMSLIB00009953947 | Gold | 4 |
COMPOUND NPA020315
PROPERTIES
| NPAID | NPA020315 |
|---|---|
| CLUSTER ID | 2664 |
| NODE ID | 2076 |
| NAME | Nystatin A1 |
| FORMULA | C47H75NO17 |
| MOLECULAR WEIGHT (Da) | 926.1070 |
| ACCURATE MASS (Da) | 925.5035 |
| ORIGIN ORGANISM TYPE | Bacterium |
| ORIGIN GENUS | Streptomyces |
| ORIGIN SPECIES | noursei |
| InChIKey | VQOXZBDYSJBXMA-NQTDYLQESA-N |
| InChI | InChI=1S/C47H75NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61,65-38)25-36(53)35(52)20-19-31(49)21-32(50)22-33(51)23-39(55)62-29(3)28(2)42(27)56/h5-6,8,10-18,27-38,40-44,46,49-54,56-58,61H,7,9,19-26,48H2,1-4H3,(H,59,60)/b6-5+,10-8+,13-11+,14-12+,17-15+,18-16+/t27-,28-,29-,30+,31+,32+,33+,34-,35+,36+,37-,38-,40+,41-,42+,43+,44-,46-,47+/m0/s1 |
| SMILES | C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H]([C@@H](CC[C@H](C[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O |
ORIGINAL ISOLATION REFERENCE
| CITATION | Borowski, E; Zielinski, J; Falkowski, L; Ziminski, T; Golik, J; Kołodziejczyk, P; Jereczek, E; Gdulewicz, M; Shenin, Y; Kotienko, T The complete structure of the polyene macrolide antibiotic nystatin A1 Tetrahedron Letters 1971 12 (8) 685-690. | ||
|---|---|---|---|
| DOI | 10.1016/S0040-4039(01)96531-1 | PMID | - |
